Breaking News

Smithers Viscient Expands

Increases market presence through investment in chemistry.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Smithers Viscient has expanded its mass spectrometry suite, saying the increased capacity will allow it to continue to provide the high level of scientific expertise and service that its clients demand. This announcement comes less than one-year since the company moved into a new custom-built laboratory in Harrogate.

“Since moving into our new state-of-the-art laboratory we have expanded our footprint and invested in both our people and cutting-edge technology to provide a superior customer service to our client base,” said David Phillips, managing director, Smithers Viscient.

Smithers Viscient recently acquired a new mass spectrometer, the Absciex Triple TOF (time of flight) 5600+. This highly sensitive and accurate instrument will be paired with a front-end Shimadzu Nexera UHPLC. These advanced machines can detect down to part-per-billion levels. According to the company, this level of detection is extremely important for detailed structural characterization, an area in which more clients are requesting expertise. The new instrument will provide additional metabolite identification and quantitative analysis to support environmental fate, ecotoxicology and product development testing at Smithers Viscient. The new equipment acquisition complements Smithers Viscient’s existing technology portfolio including Q Exactive accurate mass and API5000 mass spectrometers.

Smithers Viscient expects the new system to significantly expand capacity and broaden the lab’s capability to address a wider range of projects.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters